Metraipolis › archive › dc_defa254828f2

Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges — Europe PMC PMID:41309533

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41309533
DOI
10.1038/s41392-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-08T04:26:13.222Z
SHA-256 of the archived text
be0448f574d899679bd2736206834d47aff9dd55d5d85a0f918ea54ae731ad7c
Stable URL of this page
https://metraipolis.com/documento/dc_defa254828f2

How to cite

Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges — Europe PMC PMID:41309533 — Europe PMC (en), https://europepmc.org/article/MED/41309533 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_defa254828f2 (Metraipolis archive dc_defa254828f2, sha256 be0448f574d899679bd2736206834d47aff9dd55d5d85a0f918ea54ae731ad7c)
BibTeX
@misc{dcdefa254828f2,
  title = {Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges — Europe PMC PMID:41309533},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41309533},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_defa254828f2; sha256 be0448f574d899679bd2736206834d47aff9dd55d5d85a0f918ea54ae731ad7c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41309533. Agents can read the archived copy with the MCP tool read_document.